Capricorn Fund Sells $18.4 M of Waystar Stock, Highlighting Health‑Tech SaaS Valuation Concerns

Why It Matters

The divestiture by Capricorn Fund Managers highlights a shift in investor sentiment toward healthcare‑focused SaaS providers, a segment that has historically enjoyed premium valuations due to its perceived defensive nature. As AI reshapes the broader SaaS landscape, capital is flowing toward companies that can demonstrate clear, scalable cash‑flow benefits, putting pressure on firms like Waystar to justify growth claims with tangible profitability. For the SaaS ecosystem, the transaction serves as a barometer of how quickly institutional investors are adjusting expectations. A sizable sale from a well‑known fund can trigger re‑pricing across peer groups, influencing fundraising, M&A activity, and strategic decisions around product development and pricing models within the health‑tech niche.

Key Takeaways

• Capricorn Fund Managers sold 692,554 Waystar shares for $18.38 million in Q1 2026.
• Waystar’s stock price fell 32.5% over the past year, trading at $24.85 as of April 23 2026.
• The sale reduced Waystar to 0.17% of Capricorn’s $641.43 million U.S. equity holdings.
• Waystar reports $1.10 billion trailing‑12‑month revenue and a market cap of $4.76 billion.
• The transaction reflects broader pressure on SaaS valuations amid AI‑driven market corrections.

Pulse Analysis

Capricorn’s exit from Waystar is less about the health‑tech provider’s fundamentals and more about the macro‑environment reshaping SaaS valuations. Since the AI boom of late 2024, investors have been pruning positions in high‑growth, low‑margin SaaS firms, favoring those that can articulate a clear path to cash‑flow positivity. Waystar’s 16× free‑cash‑flow multiple, while still attractive relative to peers, now sits in a narrower band as the market re‑anchors growth expectations.

Historically, healthcare SaaS companies have benefited from the sector’s recession‑resilience, but the current environment demands more than just volume. AI integration promises efficiency gains, yet the monetization timeline remains uncertain. If Waystar can translate its AI‑enhanced denial‑prevention tools into measurable cost savings for providers, it could reclaim a premium valuation. Conversely, a prolonged earnings miss could accelerate the sector’s re‑rating, prompting further institutional exits.

Strategically, the sale signals to Waystar’s leadership that capital markets will scrutinize execution more rigorously. The company may need to accelerate its roadmap, prioritize high‑margin product lines, and communicate clearer guidance to stem investor outflows. For the broader SaaS community, Capricorn’s move serves as a cautionary tale: growth narratives must be underpinned by disciplined financial performance, especially as AI reshapes competitive dynamics across all software verticals.